PRTK Annual CFF
$5.09 M
-$13.24 M-72.22%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual cash flow from financing activities is $5.09 million, with the most recent change of -$13.24 million (-72.22%) on December 31, 2022. During the last 3 years, it has fallen by -$52.53 million (-91.16%).PRTK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly CFF
-$565.00 K
-$285.00 K-101.79%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly cash flow from financing activities is -$565.00 thousand, with the most recent change of -$285.00 thousand (-101.79%) on June 30, 2023. Over the past year, it has dropped by -$5.29 million (-111.97%).PRTK Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM CFF
-$3.57 M
-$5.29 M-308.04%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM cash flow from financing activities is -$3.57 million, with the most recent change of -$5.29 million (-308.04%) on June 30, 2023. Over the past year, it has dropped by -$25.12 million (-116.57%).PRTK TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.2% | -112.0% | -116.6% |
| 3 y3 years | -91.2% | -104.7% | -107.6% |
| 5 y5 years | -95.1% | -100.3% | -106.2% |
PRTK Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -97.7% | -100.4% | -101.5% |
Paratek Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$565.00 K(+101.8%) | -$3.57 M(-308.0%) |
| Mar 2023 | - | -$280.00 K(-89.7%) | $1.72 M(-66.3%) |
| Dec 2022 | $5.09 M(-72.2%) | -$2.73 M(<-9900.0%) | $5.09 M(-58.0%) |
| Sept 2022 | - | $1000.00(-100.0%) | $12.11 M(-43.8%) |
| June 2022 | - | $4.72 M(+52.4%) | $21.55 M(-1.3%) |
| Mar 2022 | - | $3.10 M(-27.9%) | $21.82 M(+19.0%) |
| Dec 2021 | $18.33 M(+61.7%) | $4.29 M(-54.5%) | $18.33 M(+39.3%) |
| Sept 2021 | - | $9.44 M(+88.8%) | $13.16 M(-352.3%) |
| June 2021 | - | $5.00 M(-1368.3%) | -$5.22 M(-381.4%) |
| Mar 2021 | - | -$394.00 K(-55.0%) | $1.85 M(-83.7%) |
| Dec 2020 | $11.34 M(-80.3%) | -$876.00 K(-90.2%) | $11.34 M(-69.4%) |
| Sept 2020 | - | -$8.95 M(-174.1%) | $37.06 M(-20.6%) |
| June 2020 | - | $12.07 M(+32.7%) | $46.70 M(-30.0%) |
| Mar 2020 | - | $9.09 M(-63.4%) | $66.71 M(+15.8%) |
| Dec 2019 | $57.62 M(-73.9%) | $24.84 M(+3474.8%) | $57.62 M(+75.8%) |
| Sept 2019 | - | $695.00 K(-97.8%) | $32.78 M(-21.6%) |
| June 2019 | - | $32.08 M(>+9900.0%) | $41.83 M(-75.3%) |
| Mar 2019 | - | $0.00(0.0%) | $169.03 M(-23.4%) |
| Dec 2018 | $220.73 M(+114.2%) | $0.00(-100.0%) | $220.73 M(-4.6%) |
| Sept 2018 | - | $9.74 M(-93.9%) | $231.42 M(+2.7%) |
| June 2018 | - | $159.29 M(+208.2%) | $225.39 M(+91.3%) |
| Mar 2018 | - | $51.69 M(+383.5%) | $117.84 M(+14.4%) |
| Dec 2017 | $103.03 M(+13.8%) | $10.69 M(+188.0%) | $103.03 M(-15.2%) |
| Sept 2017 | - | $3.71 M(-92.8%) | $121.56 M(+3.4%) |
| June 2017 | - | $51.74 M(+40.3%) | $117.51 M(-7.2%) |
| Mar 2017 | - | $36.88 M(+26.2%) | $126.65 M(+39.9%) |
| Dec 2016 | $90.52 M(-0.2%) | $29.22 M(-8953.6%) | $90.52 M(+46.0%) |
| Sept 2016 | - | -$330.00 K(-100.5%) | $61.99 M(-24.1%) |
| June 2016 | - | $60.88 M(+8017.1%) | $81.69 M(-10.7%) |
| Mar 2016 | - | $750.00 K(+8.1%) | $91.47 M(+0.8%) |
| Dec 2015 | $90.73 M(-8.8%) | $694.00 K(-96.4%) | $90.73 M(-57.7%) |
| Sept 2015 | - | $19.37 M(-72.6%) | $214.27 M(+9.9%) |
| June 2015 | - | $70.65 M(>+9900.0%) | $194.96 M(+95.9%) |
| Mar 2015 | - | $16.00 K(-100.0%) | $99.53 M(+0.0%) |
| Dec 2014 | $99.51 M | $124.23 M(>+9900.0%) | $99.51 M(-502.6%) |
| Sept 2014 | - | $61.00 K(-100.2%) | -$24.72 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$24.78 M(<-9900.0%) | -$24.56 M(<-9900.0%) |
| Mar 2014 | - | $1000.00(0.0%) | $232.00 K(-47.9%) |
| Dec 2013 | $445.00 K(-98.9%) | $1000.00(-99.5%) | $445.00 K(-34.2%) |
| Sept 2013 | - | $221.00 K(+2355.6%) | $676.00 K(+30.3%) |
| June 2013 | - | $9000.00(-95.8%) | $519.00 K(-98.6%) |
| Mar 2013 | - | $214.00 K(-7.8%) | $38.33 M(-1.1%) |
| Dec 2012 | $38.74 M(+2707.5%) | $232.00 K(+262.5%) | $38.74 M(-2.2%) |
| Sept 2012 | - | $64.00 K(-99.8%) | $39.60 M(+0.1%) |
| June 2012 | - | $37.82 M(+5912.6%) | $39.56 M(+1892.1%) |
| Mar 2012 | - | $629.00 K(-42.2%) | $1.99 M(+43.9%) |
| Dec 2011 | $1.38 M(+716.6%) | $1.09 M(+3929.6%) | $1.38 M(+302.3%) |
| Sept 2011 | - | $27.00 K(-88.8%) | $343.00 K(+3.0%) |
| June 2011 | - | $242.00 K(+952.2%) | $333.00 K(+84.0%) |
| Mar 2011 | - | $23.00 K(-54.9%) | $181.00 K(+7.1%) |
| Dec 2010 | $169.00 K(-105.9%) | $51.00 K(+200.0%) | $169.00 K(-28.7%) |
| Sept 2010 | - | $17.00 K(-81.1%) | $237.00 K(-56.5%) |
| June 2010 | - | $90.00 K(+718.2%) | $545.00 K(+19.8%) |
| Mar 2010 | - | $11.00 K(-90.8%) | $455.00 K(-115.8%) |
| Dec 2009 | -$2.88 M(-19.3%) | $119.00 K(-63.4%) | -$2.88 M(-56.9%) |
| Sept 2009 | - | $325.00 K(>+9900.0%) | -$6.69 M(-4.6%) |
| June 2009 | - | $0.00(-100.0%) | -$7.02 M(-1.1%) |
| Mar 2009 | - | -$3.33 M(-9.9%) | -$7.09 M(+98.6%) |
| Dec 2008 | -$3.57 M(-127.1%) | -$3.69 M(<-9900.0%) | -$3.57 M(-672.4%) |
| Sept 2008 | - | $0.00(-100.0%) | $624.00 K(-95.1%) |
| June 2008 | - | -$77.00 K(-139.3%) | $12.80 M(-4.3%) |
| Mar 2008 | - | $196.00 K(-61.2%) | $13.37 M(+1.4%) |
| Dec 2007 | $13.19 M(-67.0%) | $505.00 K(-95.9%) | $13.19 M(+3.4%) |
| Sept 2007 | - | $12.17 M(+2344.2%) | $12.76 M(+1991.0%) |
| June 2007 | - | $498.00 K(+3220.0%) | $610.00 K(-98.5%) |
| Mar 2007 | - | $15.00 K(-78.6%) | $39.42 M(-1.3%) |
| Dec 2006 | $39.93 M(+57.1%) | $70.00 K(+159.3%) | $39.93 M(+0.2%) |
| Sept 2006 | - | $27.00 K(-99.9%) | $39.86 M(+0.1%) |
| June 2006 | - | $39.31 M(+7372.8%) | $39.83 M(+7472.8%) |
| Mar 2006 | - | $526.00 K | $526.00 K |
| Dec 2005 | $25.42 M(>+9900.0%) | - | - |
| Dec 2004 | $110.00 K | - | - |
FAQ
- What is Paratek Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual CFF year-on-year change?
- What is Paratek Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly CFF year-on-year change?
- What is Paratek Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM CFF year-on-year change?
What is Paratek Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of PRTK is $5.09 M
What is the all time high annual CFF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual cash flow from financing activities is $220.73 M
What is Paratek Pharmaceuticals annual CFF year-on-year change?
Over the past year, PRTK annual cash flow from financing activities has changed by -$13.24 M (-72.22%)
What is Paratek Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of PRTK is -$565.00 K
What is the all time high quarterly CFF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly cash flow from financing activities is $159.29 M
What is Paratek Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, PRTK quarterly cash flow from financing activities has changed by -$5.29 M (-111.97%)
What is Paratek Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of PRTK is -$3.57 M
What is the all time high TTM CFF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM cash flow from financing activities is $231.42 M
What is Paratek Pharmaceuticals TTM CFF year-on-year change?
Over the past year, PRTK TTM cash flow from financing activities has changed by -$25.12 M (-116.57%)